Halie E. West , Bryan S. Kaplan , Natasha L. Mast , Randy E. Sacco
{"title":"Increased expression of the purinergic receptor P2Y6 in the bovine lung following experimental BRSV infection","authors":"Halie E. West , Bryan S. Kaplan , Natasha L. Mast , Randy E. Sacco","doi":"10.1016/j.vetimm.2025.111060","DOIUrl":null,"url":null,"abstract":"<div><div>Bovine respiratory syncytial virus (BRSV) is a major viral pathogen frequently associated with bovine respiratory disease complex. Recent studies identified P2Y6, a purinergic receptor to be involved in the recruitment of leukocytes as part of the host response to viral infections. P2Y6 is a G-protein-coupled purinergic receptor expressed by leukocytes and epithelial cells that recognizes uridine diphosphate, a danger-associated molecular pattern. P2Y6 signaling upregulates CCL-2, CXCL8, CXCL9, and CXCL10 expression. CXC chemokines were previously shown to be upregulated during BRSV infection. Adenosine receptors, G-protein-coupled purinergic receptors expressed on immune cell subsets, have immunoregulatory functions. To examine the expression of purinergic receptors and chemokines during BRSV infection, challenged Holstein calves were euthanized on 7 and 14 days post-infection (DPI) at peak and convalescing stages of infection, respectively. Real-time PCR and RNA in-situ hybridization were utilized to evaluate the expression of purinergic receptors and chemokines in lung samples. On 7 DPI, P2Y6, CXCL9, and CXCL10 were significantly upregulated. In contrast, adenosine A<sub>3</sub> receptor gene expression was lower than controls. On 14 DPI, P2Y6 expression trended higher compared to controls, while chemokine expression was decreased. Future studies are needed to examine the potential role of P2Y6 in regulating chemokine induction during BRSV infection.</div></div>","PeriodicalId":23511,"journal":{"name":"Veterinary immunology and immunopathology","volume":"292 ","pages":"Article 111060"},"PeriodicalIF":1.4000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary immunology and immunopathology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165242725001801","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Bovine respiratory syncytial virus (BRSV) is a major viral pathogen frequently associated with bovine respiratory disease complex. Recent studies identified P2Y6, a purinergic receptor to be involved in the recruitment of leukocytes as part of the host response to viral infections. P2Y6 is a G-protein-coupled purinergic receptor expressed by leukocytes and epithelial cells that recognizes uridine diphosphate, a danger-associated molecular pattern. P2Y6 signaling upregulates CCL-2, CXCL8, CXCL9, and CXCL10 expression. CXC chemokines were previously shown to be upregulated during BRSV infection. Adenosine receptors, G-protein-coupled purinergic receptors expressed on immune cell subsets, have immunoregulatory functions. To examine the expression of purinergic receptors and chemokines during BRSV infection, challenged Holstein calves were euthanized on 7 and 14 days post-infection (DPI) at peak and convalescing stages of infection, respectively. Real-time PCR and RNA in-situ hybridization were utilized to evaluate the expression of purinergic receptors and chemokines in lung samples. On 7 DPI, P2Y6, CXCL9, and CXCL10 were significantly upregulated. In contrast, adenosine A3 receptor gene expression was lower than controls. On 14 DPI, P2Y6 expression trended higher compared to controls, while chemokine expression was decreased. Future studies are needed to examine the potential role of P2Y6 in regulating chemokine induction during BRSV infection.
期刊介绍:
The journal reports basic, comparative and clinical immunology as they pertain to the animal species designated here: livestock, poultry, and fish species that are major food animals and companion animals such as cats, dogs, horses and camels, and wildlife species that act as reservoirs for food, companion or human infectious diseases, or as models for human disease.
Rodent models of infectious diseases that are of importance in the animal species indicated above,when the disease requires a level of containment that is not readily available for larger animal experimentation (ABSL3), will be considered. Papers on rabbits, lizards, guinea pigs, badgers, armadillos, elephants, antelope, and buffalo will be reviewed if the research advances our fundamental understanding of immunology, or if they act as a reservoir of infectious disease for the primary animal species designated above, or for humans. Manuscripts employing other species will be reviewed if justified as fitting into the categories above.
The following topics are appropriate: biology of cells and mechanisms of the immune system, immunochemistry, immunodeficiencies, immunodiagnosis, immunogenetics, immunopathology, immunology of infectious disease and tumors, immunoprophylaxis including vaccine development and delivery, immunological aspects of pregnancy including passive immunity, autoimmuity, neuroimmunology, and transplanatation immunology. Manuscripts that describe new genes and development of tools such as monoclonal antibodies are also of interest when part of a larger biological study. Studies employing extracts or constituents (plant extracts, feed additives or microbiome) must be sufficiently defined to be reproduced in other laboratories and also provide evidence for possible mechanisms and not simply show an effect on the immune system.